TrialESC heart failure2021

Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.

Jose Nativi-Nicolau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.